OKYO Pharma reveals update on dry eye disease candidate
Phase 2 study of OK-101 will commence soon as company hopes drug will provide unmet need
Read More
Tag: dry eye disease
Shire files dry eye drug lifitegrast in Europe
Shire has filed for approval of lifitegrast in Europe for dry eye disease in the hope of securing approval for the first treatment in a new class of drugs to address signs and symptoms of the condition.
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
